1025 Walnut Street
Jefferson Medical College Building, Room 901
Philadelphia, PA 19107
(215) 955-6086
(215) 955-5681 fax
Jefferson Medical College Building, Room 901
Philadelphia, PA 19107
(215) 955-6086
(215) 955-5681 fax
Most Recent Peer-reviewed Publications
- New advances in models and strategies for developing anti-obesity drugs
- Systems-based discovery advances drug development
- GUCY2C: At the intersection of obesity and cancer
- Translational medicine individualizes healthcare discovery, development and delivery
- Obesity pharmacotherapy: What is next?
- Immunotherapeutic strategies to target prognostic and predictive markers of cancer
- Guanylyl cyclase C as a biomarker in colorectal cancer
- Advancing pharmacometrics and systems pharmacology
- Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
- Phosphorylation of vasodilator-stimulated phosphopro 0F9B tein Ser239 suppresses filopodia and invadopodia in colon cancer
- GUCY2C molecular staging personalizes colorectal cancer patient management
- Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
- Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes
- Molecular staging individualizing cancer management
- Clinical pharmacology therapeutics 2011: Year in review
- GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity
- The Value Proposition of Molecular Medicine
- Knowledge cycle transforms therapeutic innovation
- GUCY2C-targeted cancer immunotherapy: Past, present and future
- Patient-centric clinical pharmacology advances the path to personalized medicine